Q2 2025 Krishna Institute of Medical Sciences Ltd Earnings Call Transcript
Key Points
- Krishna Institute of Medical Sciences Ltd (BOM:543308) reported a strong financial performance with a gross revenue of INR782 crores, marking a 19.4% year-on-year growth.
- The company achieved an EBITDA of INR223 crores, reflecting a 23.8% increase year-on-year, with an improved EBITDA margin of 28.5%.
- Significant expansion plans are underway, including the acquisition of Queen's NRI Hospital in Vizag and new operations in Kerala, indicating strategic growth in Tier 2 and Tier 3 towns.
- The company is focusing on asset-light models for expansion, which minimizes capital expenditure and leverages existing infrastructure.
- Krishna Institute of Medical Sciences Ltd (BOM:543308) has successfully integrated advanced medical technologies, such as robotic-assisted surgeries, enhancing its service offerings and operational efficiency.
- The occupied beds in the Telangana cluster have decreased, raising concerns about utilization despite revenue growth.
- There is a notable EBITDA loss expected from new operations in Nashik, with an anticipated loss of INR5 crores to INR10 crores in the first year.
- The company's expansion into Kerala faces competition from established local healthcare providers, which may impact market penetration.
- The promoter pledge issue remains unresolved, with ongoing queries from SEBI, potentially affecting investor confidence.
- The Andhra Pradesh cluster has seen a decline in occupancy rates, which could impact future revenue growth if not addressed.
Ladies and gentlemen, good day, and welcome to KIMS Hospital Q2 FY25 earnings conference call hosted by IIFL Securities. (Operator Instructions)
Please note that this conference is being recorded. I now hand the conference over to Mr. Rahul Jeewani from IIFL Securities. Thank you, and over to you, sir.
Yes. Thanks. Good morning, everyone. This is Rahul from IIFL Institutional Equities. I welcome you all to the second quarter earnings conference call of KIMS Hospitals.
From KIMS, we have with us Dr. Bhaskara Rao Bollineni, Founder and Managing Director; Dr. Abhinay Bollineni, Executive Director and CEO; Mr. Sachin Salvi, CFO; Dr. Nitish Shetty, CEO for KIMS Bangalore cluster; and Mr. Sreenath Reddy, Director, Business Strategy and M&A. Over to you, sir, for your opening comments.
Yes. Good morning, and a warm welcome to all of you.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
